When and where do hip fractures occur? A population-based study B. LeavyA. C. ÅbergL. Byberg Original Article 27 March 2013 Pages: 2387 - 2396
Does frailty predict increased risk of falls and fractures? A prospective population-based study O. J. de VriesG. M. E. E. PeetersD. J. H. Deeg Original Article 22 February 2013 Pages: 2397 - 2403
Associations between adverse social position and bone mineral density in women aged 50 years or older: data from the Manitoba Bone Density Program S. L. BrennanW. D. LeslieL. M. Lix Original Article 22 February 2013 Pages: 2405 - 2412
Epidemiology of proximal humeral fractures in Austria between 1989 and 2008 H. P. DimaiA. SvedbomF. Borgström Original Article 09 April 2013 Pages: 2413 - 2421
A conceptual and disease model framework for osteoporotic kyphosis M. BaylissC. MiltenburgerL. Alvares Original Article 28 March 2013 Pages: 2423 - 2432
Sclerostin and Pref-1 have differential effects on bone mineral density and strength parameters in adolescent athletes compared with non-athletes P. K. FazeliK. E. AckermanM. Misra Original Article 12 April 2013 Pages: 2433 - 2440
Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone L. KarimS. Y. TangD. Vashishth Original Article 08 March 2013 Pages: 2441 - 2447
Missense polymorphisms of the WNT16 gene are associated with bone mass, hip geometry and fractures C. García-IbarbiaM. I. Pérez-NúñezJ. A. Riancho Original Article 16 February 2013 Pages: 2449 - 2454
The predictive value of trabecular bone score (TBS) on whole lumbar vertebrae mechanics: an ex vivo study J. P. RouxJ. WegrzynR. Chapurlat Original Article 07 March 2013 Pages: 2455 - 2460
Bone mineral loss at the proximal femur in acute spinal cord injury W. B. EdwardsT. J. SchnitzerK. L. Troy Original Article 07 March 2013 Pages: 2461 - 2469
Trajectories of femoral neck strength in relation to the final menstrual period in a multi-ethnic cohort S. IshiiJ. A. CauleyA. S. Karlamangla Original Article 22 February 2013 Pages: 2471 - 2481
Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and over J.-P. RoussyL. BessetteJ. Lachaine Original Article 16 March 2013 Pages: 2483 - 2492
Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study S. R. MajumdarS. N. MorinW. D. Leslie Original Article 10 April 2013 Pages: 2493 - 2498
Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women M. H. J. KnapenN. E. DrummenE. Theuwissen Original Article 23 March 2013 Pages: 2499 - 2507
Primary non-adherence to bisphosphonates in an integrated healthcare setting K. ReynoldsP. MuntnerC. D. O’Malley Original Article 18 April 2013 Pages: 2509 - 2517
Bisphosphonate treatment may reduce osteoporosis risk in female cancer patients with morphine use: a population-based nested case–control study C. W.-S. LeeC.-H. MuoC.-H. Kao Original Article 08 March 2013 Pages: 2519 - 2524
Association between teriparatide adherence and healthcare utilization and costs in real-world US kyphoplasty/vertebroplasty patients Y. ZhaoS. S. JohnstonJ. Krege Original Article 26 March 2013 Pages: 2525 - 2533
Changes in bone mineral density and body composition of children with well-controlled homocystinuria caused by CBS deficiency J. S. LimD. H. Lee Case Report 18 May 2013 Pages: 2535 - 2538
Osteocalcin and its association with testosterone in patients with metabolic diseases G. StrapazzonA. GarollaC. Foresta Letter 29 September 2012 Pages: 2539 - 2540